Can measuring brain function help us choose an antidepressant? ↗
An editorial connection between questions, not a claim that the studies demonstrate the same mechanism or outcome.
R&D Allocation · TOPIC v1
Who Will Build the Systems to Oversee Clinical AI?
Who checks clinical AI decisions, and how is that supervision itself evaluated?
Read article → Who Will Build the Systems to Oversee Clinical AI?
2026-09-23 09:08:41.974 UTC · Last recorded update
CURRENT READING
ARPA-H announced ADVOCATE development plans covering patient-facing AI, supervision, implementation and independent evaluation.
Recorded editorial state, not a maturity score
- Program and awardsRecorded
- DevelopmentUnverified
- Clinical evaluationUnverified
- AuthorizationUnverified
New question opened · v1
Published the analysis and recorded the next checks.
Permanent link to this revision ↗01 / WHAT WE TRACK
Who checks clinical AI decisions, and how is that supervision itself evaluated?
02 / EVIDENCE & TECHNOLOGY
Clinical AI / supervisory AI / audit records / clinical evaluation
03 / EDITORIAL READING
Who checks clinical AI decisions, and how is that supervision itself evaluated?
04 / WHAT REMAINS UNKNOWN
These are awarded development plans, not announcements of authorized products or demonstrated clinical benefit.
05 / NEXT CHECK
Missed errors, false alarms, appropriate clinical handoffs and evaluation in routine care.
A hypothesis to keep honest
HYPOTHESIS · NOT YET TESTEDBuilding supervision and independent evaluation into development may help clinical AI work in practice.
What would change our view: Reconsider if supervision adds workload without reducing consequential errors.
A prospective test proposal, not a prediction score. A graph connection does not validate this hypothesis.
Linked people & organizations
Open an entity to find its cardsINSTITUTION / INFRASTRUCTUREARPA-H ↗
Who checks clinical AI decisions, and how is that supervision itself evaluated?
Related questions, optional follows
Map ↗What does an AI business sell when it helps run a clinical trial? ↗
Trial infrastructure and clinical AI oversight are different programmes, compared here through validation and responsibility.
Latest card updates
Latest 5 · editorial record dates- v1 · 2026-09-23 09:08:41.974 UTCNew question opened
Published the analysis and recorded the next checks.
Reading at the time: ARPA-H announced ADVOCATE development plans covering patient-facing AI, supervision, implementation and independent evaluation.
Earlier updates (0)
Earlier entries will appear here once more than five reader-facing revisions have accumulated.
Background readings
Source dates and verification scope
公式プログラム ↗
arpa-h.gov · accessed 2026-09-23 · public-source
採択発表 ↗
arpa-h.gov · accessed 2026-09-23 · public-source
監督AIの採択詳細 ↗
arpa-h.gov · accessed 2026-09-23 · public-source
実装の採択詳細 ↗
arpa-h.gov · accessed 2026-09-23 · public-source